Evidence map›Paper›PMID 38577179›Full record

Trial reportWorld journal of gastroenterology2024

Clinical manifestation, lifestyle, and treatment patterns of chronic erosive gastritis: A multicenter real-world study in China.

Ying-Yun Yang, Ke-Min Li, Gui-Fang Xu, Cheng-Dang Wang, Hua Xiong, Xiao-Zhong Wang, Chun-Hui Wang, Bing-Yong Zhang, Hai-Xing Jiang, Jing Sun and 11 more

Open access · hybridAbstract readMulticenter StudyClinical Trial
In one paragraph

Trial report in World journal of gastroenterology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 1 country.

Ying-Yun YangDepartment of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Ke-Min LiDepartment of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Gui-Fang XuDepartment of Gastroenterology, Nanjing Drum Tower Hospital, Nanjing 21000, Jiangsu Province, China.
Cheng-Dang WangDepartment of Gastroenterology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian Province, China.
Hua XiongDepartment of Gastroenterology, Renji Hospital, Shanghai 200127, China.
Xiao-Zhong WangDepartment of Gastroenterology, Union Hospital of Fujian Medical University, Fuzhou 350000, Fujian Province, China.
Chun-Hui WangDepartment of Gastroenterology, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China.
Bing-Yong ZhangDepartment of Gastroenterology and Hepatology, The People's Hospital of Zhengzhou University, The Henan Provincial People's Hospital, Zhengzhou 450003, Henan Province, China.
Hai-Xing JiangDepartment of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Jing SunRuijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai Jiao Tong Univesrity, Ruijin Hospital, School Medicine, Shanghai 200025, China.
Yan XuDepartment of Gastroenterology and Hepatology, China-Japan Union Hospital of Jilin University, Changchun 130033, Jilin Province, China.
Li-Juan ZhangDepartment of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou 350001, Fujian Province, China.
Hao-Xuan ZhengDepartment of Gastroenterology, Nanfang Hospital, Guangzhou 510080, Guangdong Province, China.
Xiang-Bin XingDepartment of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China.
Liang-Jing WangDepartment of Gastroenterology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou 310000, Zhejiang Province, China.
Xiu-Li ZuoDepartment of Gastroenterology, Shandong University Qilu Hospital, Jinan 250012, Shandong Province, China.
Shi-Gang DingDepartment of Gastroenterology, Peking University Third Hospital, Beijing 100191, China.
Rong LinDepartment of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China.
Chun-Xiao ChenDepartment of Gastroenterology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 315000, Zhejiang Province, China.
Xing-Wei WangDepartment of Gastroenterology, Chongqing Daping Hospital, Chongqing 400042, China.
Jing-Nan LiDepartment of Gastroenterology, Peking Union Medical College Hospital, Beijing 100005, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNFirst Affiliated Hospital of Fujian Medical University · CNGuangxi Medical University · CNHuazhong University of Science and Technology · CNPeking Union Medical College Hospital · CNPeking University · CNQilu Hospital of Shandong University · CNSichuan University · CNThe First Affiliated Hospital, Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough chronic erosive gastritis (CEG) is common, its clinical characteristics have not been fully elucidated. The lack of consensus regarding its treatment has resulted in varied treatment regimens.

aimTo explore the clinical characteristics, treatment patterns, and short-term outcomes in CEG patients in China.

methodsWe recruited patients with chronic non-atrophic or mild-to-moderate atrophic gastritis with erosion based on endoscopy and pathology. Patients and treating physicians completed a questionnaire regarding history, endoscopic findings, and treatment plans as well as a follow-up questionnaire to investigate changes in symptoms after 4 wk of treatment.

resultsThree thousand five hundred sixty-three patients from 42 centers across 24 cities in China were included. Epigastric pain (68.0%), abdominal distension (62.6%), and postprandial fullness (47.5%) were the most common presenting symptoms. Gastritis was classified as chronic non-atrophic in 69.9% of patients. Among those with erosive lesions, 72.1% of patients had lesions in the antrum, 51.0% had multiple lesions, and 67.3% had superficial flat lesions. In patients with epigastric pain, the combination of a mucosal protective agent (MPA) and proton pump inhibitor was more effective. For those with postprandial fullness, acid regurgitation, early satiety, or nausea, a MPA appeared more promising.

conclusionCEG is a multifactorial disease which is common in Asian patients and has non-specific symptoms. Gastroscopy may play a major role in its detection and diagnosis. Treatment should be individualized based on symptom profile.

Indexed as

GastritisGastritis, AtrophicHelicobacter InfectionsHelicobacter pyloriStomach UlcerEast Asian PeopleGastric MucosaGastroscopyHumansLife StylePainChronic erosive gastritisEndoscopic findingsReal-worldSymptomTreatment pattern

Identifiers

PMID38577179
PMCPMC10989489
OpenAlexW4392481453

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.